Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Statistics in Medicine
|
November 17, 2022
Commentary on "Target estimands for population-adjusted indirect comparisons"
Anja Schiel
The Lancet. Oncology
|
January 1, 2022
Assessment of tumour-agnostic therapies in basket trials
Olivier Collignon, Martin Posch, Anja Schiel
Clinical Pharmacology and Therapeutics
|
June 25, 2020
Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019
Olli Tenhunen, Florian Lasch, Anja Schiel, et al.
Clinical Pharmacology and Therapeutics
|
January 28, 2021
Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome
Olivier Collignon, Carl-Fredrik Burman, Martin Posch, et al.
British Journal of Clinical Pharmacology
|
November 25, 2020
Towards a better use of scientific advice for developers of advanced therapies
Anna Tavridou, Dolca Rogers, Milton Bonelli, et al.
Alzheimer Disease and Associated Disorders
|
January 10, 2025
Time Delay: Searching for a Meaningful Outcome of Disease Modification in Alzheimer Disease: A Report of the Educational Symposium Held at ISPOR Europe 2023
Anja Schiel, Niels Juul Brogaard, Julie Hahn-Pedersen, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
February 23, 2026
Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives
Jeanette Köppe, Anja Schiel, Christoph Gerlinger, et al.
Clinical Pharmacology and Therapeutics
|
March 7, 2022
Estimands and Complex Innovative Designs
Olivier Collignon, Anja Schiel, Carl-Fredrik Burman, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs
Cornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Pharmaceutical Statistics
|
April 28, 2021
The use of external controls: To what extent can it currently be recommended?
Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Statistics in Medicine
|
November 17, 2022
Commentary on "Target estimands for population-adjusted indirect comparisons"
Anja Schiel
The Lancet. Oncology
|
January 1, 2022
Assessment of tumour-agnostic therapies in basket trials
Olivier Collignon, Martin Posch, Anja Schiel
Clinical Pharmacology and Therapeutics
|
June 25, 2020
Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019
Olli Tenhunen, Florian Lasch, Anja Schiel, et al.
Clinical Pharmacology and Therapeutics
|
January 28, 2021
Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome
Olivier Collignon, Carl-Fredrik Burman, Martin Posch, et al.
British Journal of Clinical Pharmacology
|
November 25, 2020
Towards a better use of scientific advice for developers of advanced therapies
Anna Tavridou, Dolca Rogers, Milton Bonelli, et al.
Alzheimer Disease and Associated Disorders
|
January 10, 2025
Time Delay: Searching for a Meaningful Outcome of Disease Modification in Alzheimer Disease: A Report of the Educational Symposium Held at ISPOR Europe 2023
Anja Schiel, Niels Juul Brogaard, Julie Hahn-Pedersen, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
February 23, 2026
Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives
Jeanette Köppe, Anja Schiel, Christoph Gerlinger, et al.
Clinical Pharmacology and Therapeutics
|
March 7, 2022
Estimands and Complex Innovative Designs
Olivier Collignon, Anja Schiel, Carl-Fredrik Burman, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs
Cornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Pharmaceutical Statistics
|
April 28, 2021
The use of external controls: To what extent can it currently be recommended?
Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Page
of 3